Favourites   Have ideas?  Sign in / Register

Positive:   Disease: Metabolic disorders ↓8.15   Pharmaceutical  ↓8.15   Disease: Central nervous system (CNS) ↓8.15 «See more»   Home ↓3.01   Respiratory therapies / Pulmanory ↓2.66   Country: Greate Britain ↓2.09

Negative:


Respiratory therapies / Pulmanory segment

ADMP Adamis Pharmaceuticals Corporation - Common Stock -10.00% -10.00% 0 + Respiratory therapies / Pulmanory, Medicine, Biopharma

+ My List
FGEN FibroGen, Inc - Common Stock 0.30% 0.30% 0 + Medicine, Cancer fight, Respiratory therapies / Pulmanory

+ My List
LQDA Liquidia Technologies, Inc. - Common Stock -4.3% -4.3% 0 + Medicine, Biopharma, Respiratory therapies / Pulmanory

+ My List
PIRS Pieris Pharmaceuticals, Inc. - Common Stock -7.06% down -5.29% -1.77 + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight

+ My List
PULM Pulmatrix, Inc. - Common Stock 2.21% 2.21% 0 + Respiratory therapies / Pulmanory

+ My List
RVPH Reviva Pharmaceuticals Holdings, Inc. - Common Stock -8.15% -8.15% 0 + Medicine, Biopharma, Pharmaceutical , Disease: Metabolic disorders, Disease: Central nervous system (CNS), Respiratory therapies / Pulmanory

+ My List
SVRA Savara, Inc. - Common Stock 11.62% up 8.3% 3.32 + Respiratory therapies / Pulmanory, Medicine

+ My List
VMD Viemed Healthcare, Inc. - Common Shares -3.01% -3.01% 0 + Respiratory therapies / Pulmanory, Medicine, Equipment, Home

+ My List
VRNA Verona Pharma plc - American Depositary Shares -2.09% -2.09% 0 + Respiratory therapies / Pulmanory, Country: Greate Britain, Medicine

+ My List
WINT Windtree Therapeutics, Inc. - Common Stock -0.77% -0.77% 0 + Biopharma, Respiratory therapies / Pulmanory, Medicine

+ My List
XAIR Beyond Air, Inc. - Common Stock -8.04% down -8.04 + Respiratory therapies / Pulmanory, Medicine, Biopharma

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.